SlideShare a Scribd company logo
1 of 26
PHARMACOKINETICS
DR M. UMAIR
Dose Response Curves/Relationships
• The interaction between the drug and the receptor can be described
by dose response curve.
• It depends on the dose of the drug and affinity of the drug to the
receptor
• There are two types of dose response relationships
Graded dose response relationship
Quantal dose response relationship
Graded dose-response Curve
• A graded response describes a drug effect which increases in
proportion to increasing drug dose.
• Graded dose-response graphs plot the response to a drug
against its concentration
• Two important things can be found by graded dose response curve
• Efficacy or maximal effect
• Potency
Efficacy and EC50
• EFFICACY
• The maximum response that can be achieved with maximum
tolerable dose of a drug is called efficacy
• EC50
• It is the concentration of drug required to produce half of the
maximum effect
Efficacy and EC50
POTENCY
• POTENCY
• Amount of a drug required to produce a desired effect is called
potency
• E.g. drug A produces effect at dose of 50 mg and drug B produces
same effect at a dose of 500mg. So drug A is more potent
FULL AGONIST
• If a drug binds to a receptor and produces maximum response, it is
known as a full agonist
• A full agonist has affinity for the receptor as well as intrinsic activity
• E.g. Epinephrine at adrenergic receptor
PARTIAL AGONIST
• Partial agonist has affinity for the receptor but produces less
response as compared to a full agonist
• E.g.
• Pindolol
ANTAGONIST
• An antagonist has affinity for the receptor but no intrinsic activity. It
produces no response when it binds to the receptor.
• Eg. Propanalol at adrenergic receptor
QUANTAL DOSE–RESPONSE RELATIONSHIPS
• A quantal response to a drug is observed in a population, and is
either present or absent in any single individual.
• Quantal dose-response graphs plot the rate of an outcome
occurrence in a population against the drug dose
• They help us to calculate
• Effective dose ED50 dose at which 50% of individuals exhibit the
specified therapeutic effect
• Toxic dose TD50 dose required to produce a defined toxic effect in
50% of subjects
• Lethal dose LD50 dose required to kill 50% of animals.
therapeutic index and therapeutic window
• The therapeutic index or ratio is the ratio of the TD50 to the ED50 , a
parameter which reflects the selectivity of a drug to elicit a desired
effect rather than toxicity.
• The larger the value, the safer the drug.
• Drugs with a narrow TI , Digoxin
• Therapeutic Index= TD50
• ED50
Therapeutic window
• The therapeutic window or range is the range between the minimum
toxic dose and the minimum therapeutic dose
• Drugs with narrow therapeutic window
• Theophylline
Clearance
• Unit volume of blood “cleared” of drug per unit time
• Rate of elimination of drug/Plasma drug concentration
• Unit = ml / min
• Eg if body has 5 liter blood and 5 mg of a drug and 1mg of that drug
is excreted It will be said that clearance is 1L/m Because 1 liter of
blood has been cleared of drug
Clearance
• Mostly occurs via liver or kidneys
• Liver Clearance
• Biotransformation of drug to metabolites. Excretion of drug into bile
• Renal Clearance
• Excretion of drug into urine
• In liver or kidney disease clearance may fall .Drug concentration may
rise . Toxicity may occur and dose may need to be decreased
• Liver and kidney are the most important organs , other organs may
be involved in clearance
Half-Life
• The half-life of a drug is the time in which the plasma concentration
of the drug decreases to half of its initial level after the peak has been
achieved.
• Depends on Vd (volume of distribution) and Clearance
• t1/2= 0.7 Vd /CL
• It takes about 5 half-lives for a drug to be roughly 97% eliminated.
First order elimination
• First order elimination kinetics:
• When a constant fraction of drug is eliminated per unit
time,depending upon the plasma concentration, it is called first order
elimination kinetics
• Most drugs follow first order elimination
Zero order elimination kinetics
• Zero order elimination kinetics:
• When a constant amount of drug is eliminated per unit time
• Zero order elimination is independent of plasma concentration.
• E.g
• ethanol
• phenytoin
• aspirin
Steady state
• Steady-state concentration (Css) occurs when the amount of a drug
being absorbed is the same amount that's being cleared from the
body
• Drugs with short half life reach steady state fast and Drugs with long
half life reach steady state slowly.
• About 5 half lives are required to reach steady state
• V
Loading dose
• For drugs with long half life it may take a long time to reach steady state, in such
cases a single large first dose can be given to achieve steady state. This dose is
called loading dose
• Loading dose =
• Desired peak concentration (mg/L) × Vd (L) / Bioavailability. (BA)
Maintenance dose
• After the loading dose is given and steady state is achieved another dose can be
given to maintain steady state. This dose is called maintenance dose
• Maintenance dose =
• Desired peak concentration (mg/L) × CL / Bioavailability(BA)

More Related Content

Similar to PHARMACOKINETICS BScN.pptx

Pharmacodynamics revised
Pharmacodynamics   revisedPharmacodynamics   revised
Pharmacodynamics revisedOmar Moatamed
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring wadalshigil84
 
Practice 4(1)_General Pharmacology.ppt
Practice 4(1)_General Pharmacology.pptPractice 4(1)_General Pharmacology.ppt
Practice 4(1)_General Pharmacology.pptMahdiZMf
 
Pharmacokinetics and pharmacodynamics
Pharmacokinetics and pharmacodynamicsPharmacokinetics and pharmacodynamics
Pharmacokinetics and pharmacodynamicsDrNidhiSharma4
 
Basic principles of pharmacology
Basic principles of pharmacologyBasic principles of pharmacology
Basic principles of pharmacologyRicha Kumar
 
Dispensing Pharmacy: Posology
Dispensing Pharmacy: PosologyDispensing Pharmacy: Posology
Dispensing Pharmacy: PosologyParag Jain
 
basicprinciplesofpharmacology-180511150709.pdf
basicprinciplesofpharmacology-180511150709.pdfbasicprinciplesofpharmacology-180511150709.pdf
basicprinciplesofpharmacology-180511150709.pdfjayantigupta9
 
Introduction of pharmacology first years
Introduction of pharmacology first yearsIntroduction of pharmacology first years
Introduction of pharmacology first yearsssuser4c546a
 
Clinical pharmackokinetics
Clinical pharmackokineticsClinical pharmackokinetics
Clinical pharmackokineticsDr Sajeena Jose
 
elimination kinetics of drugs.ppt
elimination kinetics of drugs.pptelimination kinetics of drugs.ppt
elimination kinetics of drugs.pptlaxmiyadav165230
 
Drugs & Society Chapter 5.1
Drugs & Society Chapter 5.1Drugs & Society Chapter 5.1
Drugs & Society Chapter 5.1Michelle Meyer
 
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
2 posology and pharmacodynamics midwifery 2014 E.C 2.pptwakogeleta
 
Excretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationExcretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationmohamed sanooz
 
principle of pharmacology
principle of pharmacologyprinciple of pharmacology
principle of pharmacologybahati_jr
 

Similar to PHARMACOKINETICS BScN.pptx (20)

Pharmacodynamics revised
Pharmacodynamics   revisedPharmacodynamics   revised
Pharmacodynamics revised
 
Dose response relationship
Dose response relationshipDose response relationship
Dose response relationship
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring
 
Practice 4(1)_General Pharmacology.ppt
Practice 4(1)_General Pharmacology.pptPractice 4(1)_General Pharmacology.ppt
Practice 4(1)_General Pharmacology.ppt
 
Pharmacokinetics and pharmacodynamics
Pharmacokinetics and pharmacodynamicsPharmacokinetics and pharmacodynamics
Pharmacokinetics and pharmacodynamics
 
Posology 1st sem
Posology 1st semPosology 1st sem
Posology 1st sem
 
Basic principles of pharmacology
Basic principles of pharmacologyBasic principles of pharmacology
Basic principles of pharmacology
 
Dispensing Pharmacy: Posology
Dispensing Pharmacy: PosologyDispensing Pharmacy: Posology
Dispensing Pharmacy: Posology
 
basicprinciplesofpharmacology-180511150709.pdf
basicprinciplesofpharmacology-180511150709.pdfbasicprinciplesofpharmacology-180511150709.pdf
basicprinciplesofpharmacology-180511150709.pdf
 
Introduction of pharmacology first years
Introduction of pharmacology first yearsIntroduction of pharmacology first years
Introduction of pharmacology first years
 
Clinical pharmackokinetics
Clinical pharmackokineticsClinical pharmackokinetics
Clinical pharmackokinetics
 
elimination kinetics of drugs.ppt
elimination kinetics of drugs.pptelimination kinetics of drugs.ppt
elimination kinetics of drugs.ppt
 
Drugs & Society Chapter 5.1
Drugs & Society Chapter 5.1Drugs & Society Chapter 5.1
Drugs & Society Chapter 5.1
 
Clinical pharmacokinetics
Clinical pharmacokineticsClinical pharmacokinetics
Clinical pharmacokinetics
 
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
2 posology and pharmacodynamics midwifery 2014 E.C 2.ppt
 
Excretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of eliminationExcretion of drugs and kinetics of elimination
Excretion of drugs and kinetics of elimination
 
principle of pharmacology
principle of pharmacologyprinciple of pharmacology
principle of pharmacology
 
Pharmacology.pptx
Pharmacology.pptxPharmacology.pptx
Pharmacology.pptx
 
PK- Basic terminologies.pptx
PK- Basic terminologies.pptxPK- Basic terminologies.pptx
PK- Basic terminologies.pptx
 
Pharmacodynamics
PharmacodynamicsPharmacodynamics
Pharmacodynamics
 

More from MuhammadAbbasWali

1- Nursing_Status_and_Image.pptx
1- Nursing_Status_and_Image.pptx1- Nursing_Status_and_Image.pptx
1- Nursing_Status_and_Image.pptxMuhammadAbbasWali
 
Lect 3. Pakistan Health Care System.pdf
Lect 3. Pakistan Health Care  System.pdfLect 3. Pakistan Health Care  System.pdf
Lect 3. Pakistan Health Care System.pdfMuhammadAbbasWali
 
Assessment of the Breast, Axilla _ Genitalia, Educational Platform.pptx
Assessment of the Breast, Axilla _ Genitalia, Educational Platform.pptxAssessment of the Breast, Axilla _ Genitalia, Educational Platform.pptx
Assessment of the Breast, Axilla _ Genitalia, Educational Platform.pptxMuhammadAbbasWali
 
Anti-Neoplastic Drugs-1.pptx
Anti-Neoplastic Drugs-1.pptxAnti-Neoplastic Drugs-1.pptx
Anti-Neoplastic Drugs-1.pptxMuhammadAbbasWali
 
Adolescent reproductive and sexual health.pdf
Adolescent reproductive and sexual health.pdfAdolescent reproductive and sexual health.pdf
Adolescent reproductive and sexual health.pdfMuhammadAbbasWali
 
finalppt-131008044739-phpapp02.pdf
finalppt-131008044739-phpapp02.pdffinalppt-131008044739-phpapp02.pdf
finalppt-131008044739-phpapp02.pdfMuhammadAbbasWali
 
Autoimmune disorders, Educational Platform.pptx
Autoimmune disorders, Educational Platform.pptxAutoimmune disorders, Educational Platform.pptx
Autoimmune disorders, Educational Platform.pptxMuhammadAbbasWali
 
metabolism-120323035449-phpapp01.pdf
metabolism-120323035449-phpapp01.pdfmetabolism-120323035449-phpapp01.pdf
metabolism-120323035449-phpapp01.pdfMuhammadAbbasWali
 
Lecture 3 Cell_structure_function.ppt
Lecture 3 Cell_structure_function.pptLecture 3 Cell_structure_function.ppt
Lecture 3 Cell_structure_function.pptMuhammadAbbasWali
 
Lect-4. Weight Management unit-III .pdf
Lect-4. Weight Management unit-III .pdfLect-4. Weight Management unit-III .pdf
Lect-4. Weight Management unit-III .pdfMuhammadAbbasWali
 
UNIT 03 Final Adrenergic _ Anti Adrenergic Drugs, Educational Platform.pptx
UNIT 03 Final Adrenergic _ Anti Adrenergic Drugs, Educational Platform.pptxUNIT 03 Final Adrenergic _ Anti Adrenergic Drugs, Educational Platform.pptx
UNIT 03 Final Adrenergic _ Anti Adrenergic Drugs, Educational Platform.pptxMuhammadAbbasWali
 
Loss, Death, and Grieving.pptx 222222-1.pptx
Loss, Death, and Grieving.pptx 222222-1.pptxLoss, Death, and Grieving.pptx 222222-1.pptx
Loss, Death, and Grieving.pptx 222222-1.pptxMuhammadAbbasWali
 
Lecture 10 Lymphatic System.pptx
Lecture 10 Lymphatic System.pptxLecture 10 Lymphatic System.pptx
Lecture 10 Lymphatic System.pptxMuhammadAbbasWali
 

More from MuhammadAbbasWali (20)

1- Nursing_Status_and_Image.pptx
1- Nursing_Status_and_Image.pptx1- Nursing_Status_and_Image.pptx
1- Nursing_Status_and_Image.pptx
 
Lect 3. Pakistan Health Care System.pdf
Lect 3. Pakistan Health Care  System.pdfLect 3. Pakistan Health Care  System.pdf
Lect 3. Pakistan Health Care System.pdf
 
Assessment of the Breast, Axilla _ Genitalia, Educational Platform.pptx
Assessment of the Breast, Axilla _ Genitalia, Educational Platform.pptxAssessment of the Breast, Axilla _ Genitalia, Educational Platform.pptx
Assessment of the Breast, Axilla _ Genitalia, Educational Platform.pptx
 
Anti-Neoplastic Drugs-1.pptx
Anti-Neoplastic Drugs-1.pptxAnti-Neoplastic Drugs-1.pptx
Anti-Neoplastic Drugs-1.pptx
 
Adolescent reproductive and sexual health.pdf
Adolescent reproductive and sexual health.pdfAdolescent reproductive and sexual health.pdf
Adolescent reproductive and sexual health.pdf
 
finalppt-131008044739-phpapp02.pdf
finalppt-131008044739-phpapp02.pdffinalppt-131008044739-phpapp02.pdf
finalppt-131008044739-phpapp02.pdf
 
Autoimmune disorders, Educational Platform.pptx
Autoimmune disorders, Educational Platform.pptxAutoimmune disorders, Educational Platform.pptx
Autoimmune disorders, Educational Platform.pptx
 
Lecture 1 22.07.2023.pptx
Lecture 1 22.07.2023.pptxLecture 1 22.07.2023.pptx
Lecture 1 22.07.2023.pptx
 
Unit 1 A&P.ppt
Unit 1 A&P.pptUnit 1 A&P.ppt
Unit 1 A&P.ppt
 
metabolism-120323035449-phpapp01.pdf
metabolism-120323035449-phpapp01.pdfmetabolism-120323035449-phpapp01.pdf
metabolism-120323035449-phpapp01.pdf
 
Lecture 3 Cell_structure_function.ppt
Lecture 3 Cell_structure_function.pptLecture 3 Cell_structure_function.ppt
Lecture 3 Cell_structure_function.ppt
 
Lecture 9 CVS.pptx
Lecture 9 CVS.pptxLecture 9 CVS.pptx
Lecture 9 CVS.pptx
 
Lecture 9 CVS.pptx
Lecture 9 CVS.pptxLecture 9 CVS.pptx
Lecture 9 CVS.pptx
 
Lect-4. Weight Management unit-III .pdf
Lect-4. Weight Management unit-III .pdfLect-4. Weight Management unit-III .pdf
Lect-4. Weight Management unit-III .pdf
 
UNIT 03 Final Adrenergic _ Anti Adrenergic Drugs, Educational Platform.pptx
UNIT 03 Final Adrenergic _ Anti Adrenergic Drugs, Educational Platform.pptxUNIT 03 Final Adrenergic _ Anti Adrenergic Drugs, Educational Platform.pptx
UNIT 03 Final Adrenergic _ Anti Adrenergic Drugs, Educational Platform.pptx
 
Loss, Death, and Grieving.pptx 222222-1.pptx
Loss, Death, and Grieving.pptx 222222-1.pptxLoss, Death, and Grieving.pptx 222222-1.pptx
Loss, Death, and Grieving.pptx 222222-1.pptx
 
environment.pptx
environment.pptxenvironment.pptx
environment.pptx
 
Lecture 10 Lymphatic System.pptx
Lecture 10 Lymphatic System.pptxLecture 10 Lymphatic System.pptx
Lecture 10 Lymphatic System.pptx
 
oxygenation.pptx
oxygenation.pptxoxygenation.pptx
oxygenation.pptx
 
Elimination pattern.pptx
Elimination pattern.pptxElimination pattern.pptx
Elimination pattern.pptx
 

Recently uploaded

18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application ) Sakshi Ghasle
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeThiyagu K
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentInMediaRes1
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting DataJhengPantaleon
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docxPoojaSen20
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionSafetyChain Software
 

Recently uploaded (20)

Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Hybridoma Technology ( Production , Purification , and Application )
Hybridoma Technology  ( Production , Purification , and Application  ) Hybridoma Technology  ( Production , Purification , and Application  )
Hybridoma Technology ( Production , Purification , and Application )
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Alper Gobel In Media Res Media Component
Alper Gobel In Media Res Media ComponentAlper Gobel In Media Res Media Component
Alper Gobel In Media Res Media Component
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data_Math 4-Q4 Week 5.pptx Steps in Collecting Data
_Math 4-Q4 Week 5.pptx Steps in Collecting Data
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
MENTAL STATUS EXAMINATION format.docx
MENTAL     STATUS EXAMINATION format.docxMENTAL     STATUS EXAMINATION format.docx
MENTAL STATUS EXAMINATION format.docx
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdfTataKelola dan KamSiber Kecerdasan Buatan v022.pdf
TataKelola dan KamSiber Kecerdasan Buatan v022.pdf
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 
Mastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory InspectionMastering the Unannounced Regulatory Inspection
Mastering the Unannounced Regulatory Inspection
 

PHARMACOKINETICS BScN.pptx

  • 2. Dose Response Curves/Relationships • The interaction between the drug and the receptor can be described by dose response curve. • It depends on the dose of the drug and affinity of the drug to the receptor • There are two types of dose response relationships Graded dose response relationship Quantal dose response relationship
  • 3. Graded dose-response Curve • A graded response describes a drug effect which increases in proportion to increasing drug dose. • Graded dose-response graphs plot the response to a drug against its concentration • Two important things can be found by graded dose response curve • Efficacy or maximal effect • Potency
  • 4. Efficacy and EC50 • EFFICACY • The maximum response that can be achieved with maximum tolerable dose of a drug is called efficacy • EC50 • It is the concentration of drug required to produce half of the maximum effect
  • 6. POTENCY • POTENCY • Amount of a drug required to produce a desired effect is called potency • E.g. drug A produces effect at dose of 50 mg and drug B produces same effect at a dose of 500mg. So drug A is more potent
  • 7.
  • 8. FULL AGONIST • If a drug binds to a receptor and produces maximum response, it is known as a full agonist • A full agonist has affinity for the receptor as well as intrinsic activity • E.g. Epinephrine at adrenergic receptor
  • 9. PARTIAL AGONIST • Partial agonist has affinity for the receptor but produces less response as compared to a full agonist • E.g. • Pindolol
  • 10.
  • 11. ANTAGONIST • An antagonist has affinity for the receptor but no intrinsic activity. It produces no response when it binds to the receptor. • Eg. Propanalol at adrenergic receptor
  • 12. QUANTAL DOSE–RESPONSE RELATIONSHIPS • A quantal response to a drug is observed in a population, and is either present or absent in any single individual. • Quantal dose-response graphs plot the rate of an outcome occurrence in a population against the drug dose • They help us to calculate • Effective dose ED50 dose at which 50% of individuals exhibit the specified therapeutic effect • Toxic dose TD50 dose required to produce a defined toxic effect in 50% of subjects • Lethal dose LD50 dose required to kill 50% of animals.
  • 13.
  • 14. therapeutic index and therapeutic window • The therapeutic index or ratio is the ratio of the TD50 to the ED50 , a parameter which reflects the selectivity of a drug to elicit a desired effect rather than toxicity. • The larger the value, the safer the drug. • Drugs with a narrow TI , Digoxin • Therapeutic Index= TD50 • ED50
  • 15. Therapeutic window • The therapeutic window or range is the range between the minimum toxic dose and the minimum therapeutic dose • Drugs with narrow therapeutic window • Theophylline
  • 16.
  • 17. Clearance • Unit volume of blood “cleared” of drug per unit time • Rate of elimination of drug/Plasma drug concentration • Unit = ml / min • Eg if body has 5 liter blood and 5 mg of a drug and 1mg of that drug is excreted It will be said that clearance is 1L/m Because 1 liter of blood has been cleared of drug
  • 18. Clearance • Mostly occurs via liver or kidneys • Liver Clearance • Biotransformation of drug to metabolites. Excretion of drug into bile • Renal Clearance • Excretion of drug into urine • In liver or kidney disease clearance may fall .Drug concentration may rise . Toxicity may occur and dose may need to be decreased • Liver and kidney are the most important organs , other organs may be involved in clearance
  • 19. Half-Life • The half-life of a drug is the time in which the plasma concentration of the drug decreases to half of its initial level after the peak has been achieved. • Depends on Vd (volume of distribution) and Clearance • t1/2= 0.7 Vd /CL • It takes about 5 half-lives for a drug to be roughly 97% eliminated.
  • 20. First order elimination • First order elimination kinetics: • When a constant fraction of drug is eliminated per unit time,depending upon the plasma concentration, it is called first order elimination kinetics • Most drugs follow first order elimination
  • 21. Zero order elimination kinetics • Zero order elimination kinetics: • When a constant amount of drug is eliminated per unit time • Zero order elimination is independent of plasma concentration. • E.g • ethanol • phenytoin • aspirin
  • 22.
  • 23. Steady state • Steady-state concentration (Css) occurs when the amount of a drug being absorbed is the same amount that's being cleared from the body • Drugs with short half life reach steady state fast and Drugs with long half life reach steady state slowly. • About 5 half lives are required to reach steady state
  • 24. • V
  • 25. Loading dose • For drugs with long half life it may take a long time to reach steady state, in such cases a single large first dose can be given to achieve steady state. This dose is called loading dose • Loading dose = • Desired peak concentration (mg/L) × Vd (L) / Bioavailability. (BA)
  • 26. Maintenance dose • After the loading dose is given and steady state is achieved another dose can be given to maintain steady state. This dose is called maintenance dose • Maintenance dose = • Desired peak concentration (mg/L) × CL / Bioavailability(BA)